Vedanta Biosciences Initiates Phase 2 Study for VE303

Clinical Stage company, Vedanta Biosciences developing a new category of therapies for immune-mediated diseases based on...

December 27, 2018 | Thursday | News
Merck, Pfizer to terminate Phase III JAVELIN Ovarian 100 trial of avelumab

Merck and Pfizer Inc. has announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study...

December 26, 2018 | Wednesday | News
Patrys’s drug suppresses breast cancer brain metastases, increases survival

Singapore -  Patrys Limited, a therapeutic antibody development company, is pleased to announce further pre-clinica...

December 24, 2018 | Monday | News
Weight change in middle-aged and elderly Singaporean Chinese linked to increased mortality risk

Singapore – Both moderate-to-large weight gain and weight loss, defined as a change of 10% or more in weight, amon...

December 18, 2018 | Tuesday | News
Lilly announces positive top-line results for Taltz

Eli Lilly and Company has announced that Taltz® (ixekizumab) met the primary and all major secondary endpo...

December 17, 2018 | Monday | News
Novotech CRO launches largest Oracle TMMCS in APAC

Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has i...

December 17, 2018 | Monday | News
Innovent, Incyte collaborate for 3 clinical stage products

Innovent Biologics, Inc. and Incyte have entered into a strategic collaboration agreement for three clinical-stage produ...

December 17, 2018 | Monday | News
Duke-NUS highlights potential role of bioaerosol sampling to address airborne biological threats

Singapore – As a leading global city with a high population density, Singapore is vulnerable to the introduction o...

December 11, 2018 | Tuesday | News
Tychan begins Phase I Trials for first ever yellow fever drug

Tychan, a clinical-stage biotechnology company based in Singapore, announced today that its first-in-class candidate dru...

December 7, 2018 | Friday | News
PAREXEL, Eli Lilly to develop China’s Clinical Research workforce

PAREXEL, a leading innovator of global biopharmaceutical services, has announced a new collaboration with Eli Lilly and ...

December 6, 2018 | Thursday | News
argenx collaborates with Cilag GmbH International

argenx, a clinical-stage biotechnology company has announced an exclusive, global collaboration and license agreement fo...

December 3, 2018 | Monday | News
ViaCyte Secures $80 Million Financing for Insulin-Requiring Diabetes

Clinical stage regenerative medicine company has announced an $80 million Series D financing led by Bain Capital Life Sc...

November 30, 2018 | Friday | News
Tessa appoints Dr. Ivan Horak as president of R&D

Singapore –Tessa Therapeutics, a clinical stage biopharmaceutical company focusing on cellular immunotherapy ...

November 29, 2018 | Thursday | News
DRC initiates first-ever multi-drug Ebola trial

First-ever multi drug trial for an Ebola treatment has been announced by The Ministry of Health of the Democratic Republ...

November 27, 2018 | Tuesday | News
First asian real-world experience of regorafenib presented at ESMO Asia

Singapore – A new multicenter, retrospective analysis of South Korean patients highlighted that the oral targeted ...

November 26, 2018 | Monday | News
Merck, Pfizer give information of Avelumab in Refractory Ovarian Cancer

Merck and Pfizer Inc. announced that the Phase III JAVELIN Ovarian 200 trial evaluating avelumab* alone or in combinatio...

November 20, 2018 | Tuesday | News
Vyera to Initiate Phase 1 Study of NCE for Toxoplasmosis

Vyera Pharmaceuticals, LLC  has announced that it plans to initiate a Phase 1 single ascending dose (SAD) study of ...

November 16, 2018 | Friday | News
Nashville Biosciences enters into agreement with BC Platforms

Singapore - BC Platforms, a world leader in secure genomic data management and analytics, announces an agreement with Na...

November 15, 2018 | Thursday | News